ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 199 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $40,725 | +12.8% | 11,250 | 0.0% | 0.01% | 0.0% |
| Q1 2024 | $36,113 | -34.5% | 11,250 | 0.0% | 0.01% | -40.0% |
| Q4 2023 | $55,125 | -44.5% | 11,250 | 0.0% | 0.01% | -52.4% |
| Q1 2023 | $99,338 | +15.6% | 11,250 | 0.0% | 0.02% | +16.7% |
| Q4 2022 | $85,950 | +7.4% | 11,250 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $80,000 | -12.1% | 11,250 | 0.0% | 0.02% | -4.8% |
| Q2 2022 | $91,000 | -71.2% | 11,250 | 0.0% | 0.02% | -64.4% |
| Q4 2021 | $316,000 | -17.3% | 11,250 | 0.0% | 0.06% | -24.4% |
| Q3 2021 | $382,000 | -70.7% | 11,250 | -65.3% | 0.08% | -72.3% |
| Q1 2021 | $1,304,000 | -48.6% | 32,388 | -24.5% | 0.28% | -55.1% |
| Q4 2020 | $2,538,000 | +63350.0% | 42,916 | -41.3% | 0.63% | -52.9% |
| Q3 2020 | $4,000 | -99.9% | 73,099 | -11.8% | 1.33% | +12.3% |
| Q2 2020 | $4,011,000 | +27.9% | 82,916 | -26.6% | 1.19% | +5.3% |
| Q1 2020 | $3,137,000 | – | 112,916 | – | 1.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 14,000,000 | $50,680,000 | 1.33% |
| Tejara Capital Ltd | 909,061 | $3,290,801 | 1.20% |
| Pier Capital, LLC | 1,055,299 | $3,820,182 | 0.57% |
| Soleus Capital Management, L.P. | 1,720,000 | $6,226,400 | 0.55% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 623,825 | $2,258,247 | 0.42% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $108,577,223 | 0.42% |
| ARK Investment Management | 11,412,000 | $41,311,440 | 0.37% |
| Aristotle Atlantic Partners, LLC | 2,974,188 | $10,766,561 | 0.35% |
| DDD Partners, LLC | 769,997 | $2,787,389 | 0.32% |
| Matrix Capital Management Company, LP | 11,572,590 | $41,892,776 | 0.32% |